Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy
Advanced Science · 2024-05 · 11 (18)
DOI: 10.1002/advs.202309984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 02.03.2024. Verfasst von Xufeng Lu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Zhejiang International Scientific and Technological Cooperation Base of Translational Cancer Research, The Se…. Hauptthemen laut MEDLINE: Immunotherapy, Copper, Melanoma, Experimental. Die Arbeit wurde bisher 158-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Zhejiang Province Traditional Medical Scientific Research Foundation.
Abstract (Originalsprache)
The induction of cuproptosis, a recently identified form of copper‐dependent immunogenic cell death, is a promising approach for antitumor therapy. However, sufficient accumulation of intracellular copper ions (Cu 2+ ) in tumor cells is essential for inducing cuproptosis. Herein, an intelligent cuproptosis‐inducing nanosystem is constructed by encapsulating copper oxide (CuO) nanoparticles with the copper ionophore elesclomol (ES). After uptake by tumor cells, ES@CuO is degraded to release Cu 2+ and ES to synergistically trigger cuproptosis, thereby significantly inhibiting the tumor growth of murine B16 melanoma cells. Moreover, ES@CuO further promoted cuproptosis‐mediated immune responses and reprogrammed the immunosuppressive tumor microenvironment by increasing the number of tumor‐infiltrating lymphocytes and secreted inflammatory cytokines. Additionally, combining ES@CuO with programmed cell death‐1 (PD‐1) immunotherapy substantially increased the antitumor efficacy in murine melanoma. Overall, the findings of this study can lead to the use of a novel strategy for cuproptosis‐mediated antitumor therapy, which may enhance the efficacy of immune checkpoint inhibitor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Zhejiang International Scientific and Technological Cooperation Base of Translational Cancer Research, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Med…
- Research Center of Basic Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
- Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, In…
- Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
ORCID-Profile: Xufeng Lu, Yongdong Yi, Wenhai Deng, Xiang Wang, Yingpeng Huang, Xiangyang Xue, Weijian Sun, Xian Shen
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Province Traditional Medical Scientific Research Foundation
- Medical Health Science and Technology Key Project of Zhejiang Provincial and Ministry Health Commission
- Wenzhou Natural Science Research Foundation
Zitieren
APA
Lu, X., Chen, X., Lin, C., Yi, Y., Zhao, S., Zhu, B., Deng, W., Wang, X., Xie, Z., Rao, S., Ni, Z., You, T., Li, L., Huang, Y., Xue, X., Yu, Y., Sun, W., & Shen, X. (2024). Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy. Advanced Science, 11(18). https://doi.org/10.1002/advs.202309984
Vancouver
Lu X, Chen X, Lin C, Yi Y, Zhao S, Zhu B, et al. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy. Advanced Science. 2024;11(18). doi:10.1002/advs.202309984
BibTeX
@article{Lu2024,
author = {Lu, Xufeng and Chen, Xiaodong and Lin, Chengyin and Yi, Yongdong and Zhao, Shengsheng and Zhu, Bingzi and Deng, Wenhai and Wang, Xiang and Xie, Zuoliang and Rao, Shangrui and Ni, Zhonglin and You, Tao and Li, Liyi and Huang, Yingpeng and Xue, Xiangyang and Yu, Yaojun and Sun, Weijian and Shen, Xian},
title = {Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {18},
doi = {10.1002/advs.202309984}
}
EUVIMED